Sofidel Investing $185 Million to Increase Capacity of Its Circleville, Ohio Tissue Mill
Print this Article | Send to Colleague
Sofidel announced that it is investing $185 million to increase production capacity at its tissue mill in Circleville, Ohio. The project involves the construction of a new building that will house a new Valmet DCT 200 tissue machine. The new machine will have the capacity to produce 70,000 metric tons per year.
The Circleville plant, which started-up in October of 2018, currently operates two Valmet Advantage NTT tissue machines. Each machine has the capacity to produce 70,000 metric tons per year.
"Last year, we celebrated our first 10 years in the U.S. market — 10 years of development and growth," said Luigi Lazzareschi, CEO of Sofidel. "Thanks in part to the close-knit and capable U.S. team and our excellent relationships with institutions, from the state of Ohio to the local communities that have always supported us, we open our second decade of operations in the U.S. with this investment in the Circleville plant.
"Today, Sofidel America has production sites in six states, and this operation will enable us to further meet the growing demand from our customers and continue to fuel our growth in this country," Lazzareschi added.
The new tissue production line is scheduled for start-up in the third quarter of 2025.